LuxExperience Amends Q2 FY26 Results, Correcting Weighted Average Shares and Improving EPS
summarizeSummary
LuxExperience B.V. filed an amendment to its Q2 FY26 results, significantly increasing the weighted average ordinary shares outstanding and consequently revising basic and diluted earnings per share to reflect a smaller loss.
check_boxKey Events
-
Weighted Average Shares Restatement
Weighted average ordinary shares for the three months ended December 31, 2025, were revised from 87.2 million to 140.1 million, and for the six months from 87.2 million to 139.9 million.
-
EPS Revision for Continuing Operations
Basic and diluted EPS from continuing operations for the three months ended December 31, 2025, were revised from (€0.15) to (€0.09), and for the six months from (€1.14) to (€0.71), indicating a smaller loss per share.
-
Total EPS Improvement
Total basic and diluted EPS for the three months ended December 31, 2025, improved from (€0.09) to (€0.05), and for the six months from (€1.21) to (€0.76), reflecting a reduced overall loss per share.
auto_awesomeAnalysis
This 6-K/A filing is highly important as it corrects fundamental financial metrics from the recently reported Q2 FY26 results. The weighted average ordinary shares outstanding for the three and six months ended December 31, 2025, were significantly increased (from 87.2 million to 140.1 million and 139.9 million, respectively). Despite this substantial increase in share count, the revised basic and diluted earnings per share figures for both continuing and total operations show a smaller loss, which is a favorable correction. Investors should note the improved EPS figures, but also consider the implications of such a material restatement on the reliability of financial reporting. This amendment follows closely on the heels of the initial Q2 FY26 6-K filing, indicating a rapid correction of a material error.
At the time of this filing, LUXE was trading at $10.08 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $6.18 to $12.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.